Categorias DeCS
B04 Viruses .
B04.280 DNA Viruses .
B04.280.410 Iridoviridae .
C11 Eye Diseases .
C11.250 Eye Abnormalities .
C11.250.060 Aniridia .
C11.270 Eye Diseases, Hereditary .
C11.270.060 Aniridia .
C11.941 Uveal Diseases .
C11.941.375 Iris Diseases .
C11.941.375.060 Aniridia .
C11.941.375.385 Iritis .
C11.941.879 Uveitis .
C11.941.879.780 Panuveitis .
C11.941.879.780.880 Uveitis, Anterior .
C11.941.879.780.880.448 Iritis .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.384 Eye Abnormalities .
C16.131.384.079 Aniridia .
C16.320 Genetic Diseases, Inborn .
C16.320.290 Eye Diseases, Hereditary .
C16.320.290.078 Aniridia .
D01 Inorganic Chemicals .
D01.268 Elements .
D01.268.556 Metals, Heavy .
D01.268.556.401 Iridium .
D01.268.956 Transition Elements .
D01.268.956.280 Iridium .
D01.552 Metals .
D01.552.544 Metals, Heavy .
D01.552.544.401 Iridium .
D02 Organic Chemicals .
D02.033 Alcohols .
D02.033.415 Fatty Alcohols .
D02.033.415.220 Dodecanol .
D02.033.415.220.720 Sodium Dodecyl Sulfate .
D02.455 Hydrocarbons .
D02.455.849 Terpenes .
D02.455.849.575 Monoterpenes .
D02.455.849.575.500 Iridoids .
D02.886 Sulfur Compounds .
D02.886.645 Sulfur Acids .
D02.886.645.600 Sulfonic Acids .
D02.886.645.600.055 Alkanesulfonic Acids .
D02.886.645.600.055.050 Alkanesulfonates .
D02.886.645.600.055.050.632 Sodium Dodecyl Sulfate .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.663 Pyrans .
D03.383.663.491 Iridoids .
D10 Lipids .
D10.289 Fatty Alcohols .
D10.289.220 Dodecanol .
D10.289.220.720 Sodium Dodecyl Sulfate .
E04 Surgical Procedures, Operative .
E04.540 Ophthalmologic Surgical Procedures .
E04.540.480 Iridectomy .
HP3 Homeopathic Therapeutics .
HP3.018 Complementary Therapies .
HP3.018.167 Iridology .
HP4 Materia Medica .
HP4.018 Homeopathic Remedy .
HP4.018.375 Homeopathic Remedy I .
HP4.018.375.634 Iridium Metallicum .
HP4.018.375.655 Iridium Muriaticum .
|
| | Termos
Sinônimos e Históricos | Documentos
LILACS e MDL | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
